Article: The Melanocyte Lineage Factor miR-211 Promotes BRAF Inhibitor Resistance

Resistance to targeted therapy and immunotherapy remains a major obstacle in improving care for patients with advanced melanoma. MicroRNAs play important roles in regulating gene networks involved in disease progression and resistance to therapy in cancers such as melanoma. MicroRNA miR-211 contributes to melanocyte and melanoma biology and has been implicated in targeted therapy resistance. Lee et al. (2020) report a novel mechanism by which miR-211 promotes resistance to BRAF inhibitor therapy via the upregulation of the extracellular signal-regulated kinase 5 signaling pathway.

Citing Articles

circRNA18_46222157_46248185 inhibits melanogenesis by targeting miR-211/EP300 pathway in goat melanocytes.

Ji K, Zhang X, Zhao Y, Liang C, Yuan X, Zhang Y Anim Biosci. 2024; 38(2):255-266.

PMID: 39210802 PMC: 11725754. DOI: 10.5713/ab.24.0316.

References

1.

Gomez N, Erazo T, Lizcano J . ERK5 and Cell Proliferation: Nuclear Localization Is What Matters. Front Cell Dev Biol. 2016; 4:105. PMC: 5031611. DOI: 10.3389/fcell.2016.00105. View

2.

Mazar J, Qi F, Lee B, Marchica J, Govindarajan S, Shelley J . MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma Cells. Mol Cell Biol. 2016; 36(7):1090-108. PMC: 4800793. DOI: 10.1128/MCB.00762-15. View

3.

Benito-Jardon L, Diaz-Martinez M, Arellano-Sanchez N, Vaquero-Morales P, Esparis-Ogando A, Teixido J . Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway. Cancer Res. 2019; 79(9):2244-2256. DOI: 10.1158/0008-5472.CAN-18-2762. View

4.

Lee B, Sahoo A, Sawada J, Marchica J, Sahoo S, Layng F . MicroRNA-211 Modulates the DUSP6-ERK5 Signaling Axis to Promote BRAF-Driven Melanoma Growth In Vivo and BRAF/MEK Inhibitor Resistance. J Invest Dermatol. 2020; 141(2):385-394. PMC: 9004592. DOI: 10.1016/j.jid.2020.06.038. View

5.

Lunavat T, Cheng L, Einarsdottir B, Olofsson Bagge R, Muralidharan S, Sharples R . BRAF inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells. Proc Natl Acad Sci U S A. 2017; 114(29):E5930-E5939. PMC: 5530690. DOI: 10.1073/pnas.1705206114. View

6.

Diaz-Martinez M, Benito-Jardon L, Alonso L, Koetz-Ploch L, Hernando E, Teixido J . miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma. Cancer Res. 2017; 78(4):1017-1030. PMC: 5815895. DOI: 10.1158/0008-5472.CAN-17-1318. View

7.

Boshuizen J, Koopman L, Krijgsman O, Shahrabi A, van den Heuvel E, Ligtenberg M . Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors. Nat Med. 2018; 24(2):203-212. DOI: 10.1038/nm.4472. View

8.

Levy C, Khaled M, Iliopoulos D, Janas M, Schubert S, Pinner S . Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell. 2010; 40(5):841-9. PMC: 3004467. DOI: 10.1016/j.molcel.2010.11.020. View

9.

Mazar J, DeYoung K, Khaitan D, Meister E, Almodovar A, Goydos J . The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One. 2010; 5(11):e13779. PMC: 2967468. DOI: 10.1371/journal.pone.0013779. View

10.

Adam C, Fusi L, Weiss N, Goller S, Meder K, Frings V . Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways. J Invest Dermatol. 2020; 140(12):2455-2465.e10. DOI: 10.1016/j.jid.2020.03.972. View

The Melanocyte Lineage Factor MiR-211 Promotes BRAF Inhibitor Resistance